TrialThe Lancet. Oncology2019

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.

Theodore W Laetsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.